3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia
22
Lymphoma
14
Leukemia, Myeloid, Acute
14
Myelodysplastic Syndromes
12
Leukemia, Lymphocytic, Chronic, B-Cell
12
Breast Neoplasms
11
Prostatic Neoplasms
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
9
Multiple Myeloma
9
Melanoma
9
Lymphoma, Follicular
9
Neuroblastoma
8
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
8
Ovarian Neoplasms
7
Congenital Abnormalities
7
Lymphoma, Non-Hodgkin
6
Hodgkin Disease
5
Neoplasms, Plasma Cell
4
Neoplasm Metastasis
4
Myeloproliferative Disorders
4
Lymphoma, Mantle-Cell
4
Leukemia, Myeloid, Chronic-Phase
4
Glioblastoma
4
Fallopian Tube Neoplasms
4
Anemia, Refractory, with Excess of Blasts
4
Waldenstrom Macroglobulinemia
3
Osteosarcoma
3
Lymphoma, Large-Cell, Immunoblastic
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, B-Cell, Marginal Zone
3
Interventions
etoposide phosphate
2
Radiotherapy
2
fluorodopa F 18
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Perfusion Magnetic Resonance Imaging
1
Microarray Analysis
1
Magnetic Resonance Spectroscopy
1
Lenalidomide
1
Immunologic Techniques
1
Immunohistochemistry
1
Ifosfamide
1
Etoposide
1
Dynamic Contrast Enhanced Magnetic Resonance Imaging
1
Doxorubicin
1
Donepezil
1
Dasatinib
1
Cyproheptadine
1
Cilengitide
1
Carboplatin
1
Blotting, Western
1
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Optic Nerve Glioma
×
sargramostim
×
Clear all
No trials found.